Building the first AI drug discovery company for inflammation.

An immune intelligence platform, built on the world’s largest human glycome dataset.

Chronic inflammation sits beneath the diseases that kill most of us, and it shows in our antibodies years before they appear. We have spent thirty years learning to read it. Now we are building the medicines that reverse it.